68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients

Summary

This is an open-label positron emission tomography/computed tomography(PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-RM26 in breast tumor patients. 1.85 MBq per kilogram body weight of 68Ga-NOTA-RM26A will be injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT images.

Timeline

Start

2016-10

Primary completion

2018-10

Completion

2018-10

Drugs

Indications